Pall Corp (NYSE:PLL) has a corporate mission of "making the world safer, greener and better." Its key way of doing this is through the sale of filters and related devices that remove contaminants from life science materials and water and related liquids in the industrial sector. Its businesses have great potential, but the potential for above-average shareholder returns is currently uncertain.
Investopedia Markets: Explore the best one-stop source for financial news, quotes and insights.

Second Quarter Recap
Sales advanced 8.2% to just a hair shy of $698 million. Pall breaks its operations into two divisions. The Life Sciences unit is the largest and grew 6.9% to $357.2 million, or 55.9% of second quarter sales. Pall sells technologies to help its clients research, discover, develop and produce drugs and related healthcare products. Specific products include blood filtration devices and hospital infection control systems at underlying clients that likely include Health Management Associates (NYSE:HMA) and HCA (NYSE:HCA) hospitals. The remaining $340.8 million stemmed from the Industrial segment that 9.6%. This business consists of helping industrial clients, including commercial aerospace firms such as Boeing (NYSE:BA) and industrial manufacturers such as General Electric (NYSE:GE) filter and process fluids.

Sales costs grew more slowly than sales, but operating SG&A expenses grew faster than the top line to result in operating income growth of 7.8% that slightly lagged sales growth. Operating profit came in at $123.5 million, or 17.7% of total sales for a very healthy operating profit margin. However, lower income tax expense helped send net income up 12% to $84.7 million. Share buybacks pushed per-share earnings up a bit further as earnings per diluted share increased 12.5% to 72 cents. Management estimated 76 cents in diluted earnings when looking at its recurring business. For related reading, see Zooming In On Net Operating Income.

Outlook
For the full year, analysts' project total sales growth in excess of 6% and total sales of nearly $3 billion. They expect earnings of $3.17 per share for annual growth in the neighborhood of 19%.

The Bottom Line
Nearly half of Pall's business stems from the cyclical industrial market, but its sales held up well during the credit crisis and ensuing global recession. Its Life Science focus is certainly a strong point during economic downturns, and its overall product mix appears to be stable and exposed to a strong secular trend of water and energy management, environmental and regulatory requirements and continued advances in medicine.

At a forward P/E close to 17, many investors are already aware of Pall's appealing businesses and their global growth potential. Free cash flow multiples are even higher as annual capital expenditure needs take up a higher percent of annual operating cash flow. Overall, the company is worth monitoring closely, as is the stock for a potential pull back to more reasonable valuation levels.

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!
At the time of writing Ryan C. Fuhrmann did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Stock Analysis

    Net Neutrality: Pros and Cons

    The fight over net neutrality has become an amazing spectacle. But at its core, it's yet another skirmish in cable television's war to remain relevant.
  2. Entrepreneurship

    Top 10 Side Jobs You Could Start Now

    Ways to make extra cash in your spare time.
  3. Personal Finance

    A Day in the Life of an Equity Research Analyst

    What does an equity research analyst do on an everyday basis?
  4. Mutual Funds & ETFs

    ETF Analysis: PowerShares S&P 500 Downside Hedged

    Find out about the PowerShares S&P 500 Downside Hedged ETF, and learn detailed information about characteristics, suitability and recommendations of it.
  5. Mutual Funds & ETFs

    ETF Analysis: ProShares Large Cap Core Plus

    Learn information about the ProShares Large Cap Core Plus ETF, and explore detailed analysis of its characteristics, suitability and recommendations.
  6. Mutual Funds & ETFs

    ETF Analysis: iShares Core Growth Allocation

    Find out about the iShares Core Growth Allocation Fund, and learn detailed information about its characteristics, suitability and recommendations.
  7. Mutual Funds & ETFs

    ETF Analysis: iShares MSCI USA Minimum Volatility

    Learn about the iShares MSCI USA Minimum Volatility exchange-traded fund, which invests in low-volatility equities traded on the U.S. stock market.
  8. Stock Analysis

    Should You Follow Millionaires into This Sector?

    Millionaire investors—and those who follow them—should take another look at the current economic situation before making any more investment decisions.
  9. Professionals

    What to do During a Market Correction

    The market has corrected...now what? Here's what you should consider rather than panicking.
  10. Mutual Funds & ETFs

    ETF Analysis: Vanguard Mid-Cap Value

    Take an in-depth look at the Vanguard Mid-Cap Value ETF, one of the largest and most popular mid-cap funds in the U.S. equity space.
RELATED TERMS
  1. Equity

    The value of an asset less the value of all liabilities on that ...
  2. Hard-To-Sell Asset

    An asset that is extremely difficult to dispose of either due ...
  3. Sucker Yield

    When an investor has essentially risked all of his capital for ...
  4. PT (Perseroan Terbatas)

    An acronym for Perseroan Terbatas, which is Limited Liability ...
  5. Ltd. (Limited)

    An abbreviation of "limited," Ltd. is a suffix that ...
  6. BHD (Berhad)

    The suffix Bhd. is an abbreviation of a Malay word "berhad," ...
RELATED FAQS
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>

You May Also Like

COMPANIES IN THIS ARTICLE
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!